Richmond Pharmacology (RPL) will be attending this month�s 22nd Annual DIA EuroMeeting, taking place 8-10 March 2010 in Monaco.The DIA Annual EuroMeeting features more than 110 hot-topic sessions across 13 themes and attracts more than 3,000 professionals from the biopharmaceutical industry, contract service organisations, regulatory agencies, health ministries and academia, as well as patients and students worldwide.Themes are based on an integrated multidisciplinary approach that will generate interest from as many disciplines as possible. This year�s themes include:

  • Innovation
  • Staying in Business: How to Make Sure You Comply with All Rules and Regulations
  • Paediatric Medicines on Their Way to Patients
  • Decision Making: The Key to Efficient and Effective Drug Development, approval, and access
  • Paving the Way for Advanced Therapies: Fostering New Generations of Biotechnology-Derived Medicines
  • Challenges for Switching from Prescription to Non-Prescription Status through the Centralised Procedure
  • Personalised Medicines: What Is It, Where Do We Stand, and Where Are We Going?
  • Taking the European Regulatory Infrastructure Forward
  • Risk Management
  • The Informed Patient
  • eHealth
  • Pharmaceutical Sciences in 2020
  • Handling Clinical Trials, eSubmissions and Quality Requests

Click here to download advanced programme.RPL will be exhibiting at this year�s DIA EuroMeeting to inform key decision makers in the industry of our expertise and experience in the field of Early Phase Research. The EuroMeeting is a key event in the calendar and this forum provides an ideal opportunity to meet with existing clients, network and connect with new prospective sponsors. Planning to attend? We look forward to seeing you in Monaco next month!

Latest news

Futureproofing early phase clinical research for the next generation of investigators.

March 20, 2023
Richmond Pharmacology’s experienced Principal investigators and Co-investigators recently gave expert feedback on the ICH M11 (CeSHarP) protocol template.
Read more

Director of Operations, Keith Berelowitz, has been appointed as the Research Ethics Committee Chair for the Health Research Authority.

January 19, 2023
Keith Berelowitz will be responsible for ensuring that all ethical possibilities are explored in relation to new research.
Read more

Events

13th International Workshop on Regulatory Requirements and Current Scientific Aspects on the Preclinical and Clinical Investigation of Drug-Drug Interactions

Sunday, June 4th to Tuesday June 6th 2023
Exchange research-based knowledge on drug-drug interactions (DDIs) among all interested stakeholders from pharmaceutical industry, regulatory authorities, academic and health care delivery backgrounds and perspectives.
View event